• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, December 14, 2018


Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

A study published in The American Journal of Managed Care® (AJMC®) was mentioned in an article from Health Leaders Media. The study, “High-Touch Care Leads to Better Outcomes and Lower Costs in a Senior Population,” evaluated the impact of a high-touch primary care model among a Medicare Advantage population in comparison with a standard practice—based model. Researchers concluded that those receiving high-touch care had lower healthcare costs and fewer hospitalizations.

OBR Oncology’s Tuesday daily newsfeed included 3 articles from AJMC®. The first article, “Value of Breast Cancer Tests Highlighted in San Antonio,” covered data being presented at the San Antonio Breast Cancer Symposium on competing tests that direct breast cancer treatment. The article “What Might Come After the Oncology Care Model” suggested that while the model is likely not a sustainable model for oncology care, it will probably inform what payment structure comes next. The third article, “More Than 300 Groups Seek Halt to CMS’ Plans for Global Drug Pricing Index,” covered the news that a large coalition of medical associations, patient advocacy groups, drug companies, and others sent a letter to Congress asking that they intervene in CMS’ plan for a global drug pricing index, saying it would negatively affect the elderly and people with disabilities.

The National Pharmaceutical Council’s Wednesday CER Daily Newsfeed included an AJMC® interview with Brian Koffman, MDCM, DCFP, DABFM, MS Ed, medical director, CLL Society. During the interview, Koffman explained how patient-reported outcomes can provide insight into chimeric antigen receptor T-cell therapy.

Related Videos
Video 3 - "Overview of BCG-Unresponsive Bladder Cancer Treatments Landscape"
Video 2 - "Bladder Cancer with FGFR Alterations: THOR-2 Cohort 1 Study at ESMO 2023"
Video 1 - "Biomarkers and Molecular/ Genomic Testing in Genitourinary Cancers"
Landman family
Related Content
© 2023 MJH Life Sciences
All rights reserved.